Evidence map›Paper›PMID 21126552›Full record

ArticlePeptides2011

Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.

M S Parker, R Sah, A Balasubramaniam, F R Sallee, O Zerbe, S L Parker

Abstract read
In one paragraph

Article in Peptides, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. The role of PYY in improving insulin resistance.Frontiers in endocrinology · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

M S ParkerDepartment of Molecular Cell Sciences, Univ. of Memphis, Memphis, TN 38152, USA.
R Sah
A Balasubramaniam
F R Sallee
O Zerbe
S L Parker
University of Cincinnati · USUniversity of Basel · CHUniversity of Memphis · USUniversity of Tennessee Health Science Center · US

Funding

BRAIN MONOAMINES AND LUTEINIZING HORMONE SECRETIONR01HD013703 · NICHD · UNIVERSITY OF UTAH · PI CROWLEY, WILLIAM R · 1985 to 2003
$786k
NICHD NIH HHS R01 HD013703NICHD NIH HHS R01 HD-13703
6 · The paper itself

Abstract

Non-specific binding of Y receptor agonists to intact CHO cells, and to CHO cell or rat brain particulates, is much greater for human neuropeptide Y (hNPY) compared to porcine peptide Y (pPYY), and especially relative to human pancreatic polypeptide (hPP). This binding of hNPY is reduced by alkali cations in preference to non-ionic chaotrope urea, while the much lower non-specific binding of pPYY is more sensitive to urea. The difference could mainly be due to the 10-16 stretch in 36-residue Y agonists (residues 8-14 in N-terminally clipped 34-peptides), located in the sector that contains all acidic residues of physiological Y agonists. Anionic pairs containing aspartate in the 10-16 zone could be principally responsible for non-specific attachments, but may also aid the receptor site binding. Two such pairs are found in hNPY, one in pPYY, and none in hPP. The hydroxyl amino acid residue at position 13 in mammalian PYY and PP molecules could lower conformational plasticity and the non-selective binding via intrachain hydrogen bonding. The acidity of this tract could also be important in agonist selectivity of the Y receptor subtypes. The differences point to an evolutionary reduction of promiscuous protein binding from NPY to PP, and should also be important for Y agonist selectivity within NPY receptor group, and correlate with partial agonism and out-of group cross-reactivity with other receptors.

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsBinding SitesCell MembraneCerebral CortexCHO CellsCricetinaeCricetulusDetergentsGastrointestinal HormonesHEK293 CellsHumansMiceMolecular Sequence DataNeuropeptidesDetergentsGastrointestinal HormonesNeuropeptidesNeuropeptide Yneuropeptide Y2 receptorneuropeptide Y4 receptorneuropeptide Y5 receptorneuropeptide Y-Y1 receptorPancreatic PolypeptidePeptide FragmentsPeptide HormonesPeptide YYpeptide YY (3-36)peptide YY, iodo-Leu(34)-Pro(34)-PerchloratesReceptors, Neuropeptide YSodium Compoundssodium perchlorateUrea

Identifiers

PMID21126552
PMCPMC3025077
OpenAlexW1988850937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.